BCPC

BalchemNasdaqGS:BCPC Stock Report

Market Cap

US$4.5b

7D

-0.007%

1Y

46.0%

Updated

16 Sep, 2021

Data

Company Financials +
BCPC fundamental analysis
Snowflake Score
Valuation0/6
Future Growth2/6
Past Performance3/6
Financial Health6/6
Dividends0/6

BCPC Overview

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally.

Share Price & News

How has Balchem's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: BCPC is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 2% a week.

Volatility Over Time: BCPC's weekly volatility (2%) has been stable over the past year.


Market Performance


7 Day Return

-0.007%

BCPC

-0.1%

US Chemicals

-0.6%

US Market


1 Year Return

46.0%

BCPC

23.0%

US Chemicals

33.7%

US Market

Return vs Industry: BCPC exceeded the US Chemicals industry which returned 22.3% over the past year.

Return vs Market: BCPC exceeded the US Market which returned 30.7% over the past year.


Shareholder returns

BCPCIndustryMarket
7 Day-0.007%-0.1%-0.6%
30 Day6.5%-1.1%1.4%
90 Day7.2%2.3%5.4%
1 Year46.8%46.0%25.3%23.0%35.7%33.7%
3 Year21.5%19.5%38.2%17.8%61.2%51.2%
5 Year103.8%98.5%96.4%58.6%123.8%99.4%

Long-Term Price Volatility Vs. Market

How volatile is Balchem's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Balchem Fundamentals Summary

How do Balchem's earnings and revenue compare to its market cap?
BCPC fundamental statistics
Market CapUS$4.50b
Earnings (TTM)US$89.87m
Revenue (TTM)US$743.87m

50.1x

P/E Ratio

6.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
BCPC income statement (TTM)
RevenueUS$743.87m
Cost of RevenueUS$512.51m
Gross ProfitUS$231.36m
ExpensesUS$141.49m
EarningsUS$89.87m

Last Reported Earnings

Jun 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)2.79
Gross Margin31.10%
Net Profit Margin12.08%
Debt/Equity Ratio14.6%

How did BCPC perform over the long term?

See historical performance and comparison

Dividends

0.4%

Current Dividend Yield

21%

Payout Ratio

Valuation

Is Balchem undervalued compared to its fair value and its price relative to the market?

50.11x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: BCPC ($139.12) is trading above our estimate of fair value ($77.79)

Significantly Below Fair Value: BCPC is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: BCPC is poor value based on its PE Ratio (50.1x) compared to the US Chemicals industry average (21.7x).

PE vs Market: BCPC is poor value based on its PE Ratio (50.1x) compared to the US market (17.1x).


Price to Earnings Growth Ratio

PEG Ratio: BCPC is poor value based on its PEG Ratio (3.3x)


Price to Book Ratio

PB vs Industry: BCPC is overvalued based on its PB Ratio (5.2x) compared to the US Chemicals industry average (2.6x).


Future Growth

How is Balchem forecast to perform in the next 1 to 3 years based on estimates from 5 analysts?

15.2%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: BCPC's forecast earnings growth (15.2% per year) is above the savings rate (2%).

Earnings vs Market: BCPC's earnings (15.2% per year) are forecast to grow faster than the US market (14.8% per year).

High Growth Earnings: BCPC's earnings are forecast to grow, but not significantly.

Revenue vs Market: BCPC's revenue (6.7% per year) is forecast to grow slower than the US market (9.5% per year).

High Growth Revenue: BCPC's revenue (6.7% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if BCPC's Return on Equity is forecast to be high in 3 years time


Past Performance

How has Balchem performed over the past 5 years?

7.2%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: BCPC has high quality earnings.

Growing Profit Margin: BCPC's current net profit margins (12.1%) are lower than last year (12.2%).


Past Earnings Growth Analysis

Earnings Trend: BCPC's earnings have grown by 7.2% per year over the past 5 years.

Accelerating Growth: BCPC's earnings growth over the past year (9.7%) exceeds its 5-year average (7.2% per year).

Earnings vs Industry: BCPC earnings growth over the past year (9.7%) underperformed the Chemicals industry 41.2%.


Return on Equity

High ROE: BCPC's Return on Equity (10.3%) is considered low.


Financial Health

How is Balchem's financial position?


Financial Position Analysis

Short Term Liabilities: BCPC's short term assets ($287.3M) exceed its short term liabilities ($100.8M).

Long Term Liabilities: BCPC's short term assets ($287.3M) exceed its long term liabilities ($203.2M).


Debt to Equity History and Analysis

Debt Level: BCPC's debt to equity ratio (14.6%) is considered satisfactory.

Reducing Debt: BCPC's debt to equity ratio has reduced from 65.2% to 14.6% over the past 5 years.

Debt Coverage: BCPC's debt is well covered by operating cash flow (125.5%).

Interest Coverage: BCPC's interest payments on its debt are well covered by EBIT (38.9x coverage).


Balance Sheet


Dividend

What is Balchem current dividend yield, its reliability and sustainability?

0.42%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: BCPC's dividend (0.42%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.36%).

High Dividend: BCPC's dividend (0.42%) is low compared to the top 25% of dividend payers in the US market (3.6%).


Stability and Growth of Payments

Stable Dividend: BCPC is not paying a notable dividend for the US market, therefore no need to check if payments are stable.

Growing Dividend: BCPC is not paying a notable dividend for the US market, therefore no need to check if payments are increasing.


Current Payout to Shareholders

Dividend Coverage: BCPC is not paying a notable dividend for the US market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of BCPC's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

4.0yrs

Average management tenure


CEO

Ted Harris (56 yo)

6.42yrs

Tenure

US$4,647,076

Compensation

Mr. Theodore L. Harris, also known as Ted, has been the Chief Executive Officer and President at Balchem Corporation since April 28, 2015. He serves as an Independent Director of Pentair Plc since April 30...


CEO Compensation Analysis

Compensation vs Market: Ted's total compensation ($USD4.65M) is about average for companies of similar size in the US market ($USD5.19M).

Compensation vs Earnings: Ted's compensation has increased by more than 20% in the past year.


Leadership Team

Experienced Management: BCPC's management team is considered experienced (4 years average tenure).


Board Members

Experienced Board: BCPC's board of directors are considered experienced (5.3 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: BCPC insiders have only sold shares in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Balchem Corporation's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Balchem Corporation
  • Ticker: BCPC
  • Exchange: NasdaqGS
  • Founded: 1967
  • Industry: Specialty Chemicals
  • Sector: Materials
  • Market Cap: US$4.503b
  • Shares outstanding: 32.37m
  • Website: https://www.balchem.com

Number of Employees


Location

  • Balchem Corporation
  • 52 Sunrise Park Road
  • New Hampton
  • New York
  • 10958
  • United States

Listings


Biography

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutritio...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/09/16 05:01
End of Day Share Price2021/09/15 00:00
Earnings2021/06/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.